The Immunotherapy Against Swine Disease
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Veterinary Vaccines".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 331
Special Issue Editors
Interests: porcine epidemic diarrhea virus; other swine infectious viruses
Interests: porcine reproductive and respiratory syndrome virus; other swine infectious viruses; live vector vaccine
Interests: porcine reproductive and respiratory syndrome virus; other swine infectious viruses
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The Special Issue, entitled "The Immunotherapy Against Swine Disease", aims to explore recent advancements in immunotherapeutic strategies targeting viral and bacterial diseases that significantly affect both the swine industry and overall animal health. Emphasizing the importance of innovative approaches, we invite studies focused on vaccine development, monoclonal antibodies, and host immune modulation as essential components in enhancing swine health outcomes. This Special Issue serves as a platform for researchers to present their findings, examine emerging technologies, and address the challenges inherent in implementing immunotherapy within swine populations. We encourage submissions that encompass both basic and applied research, particularly those investigating immunological responses, the efficacy of various therapeutic modalities, and comparative analyses. Through this initiative, our goal is to stimulate collaboration and deepen our understanding of effective immunotherapeutic interventions in the swine industry.
We look forward to receiving your contributions.
Prof. Dr. Changlong Liu
Prof. Dr. Fei Gao
Prof. Dr. Yanhua Li
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunotherapy
- swine infectious diseases
- vaccines
- monoclonal antibodies
- immune modulation
- viral infections
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
